-
1
-
-
3142726157
-
Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
-
Badesch DB, Abman SH, Ahearn GS, Barst RJ, Simonneau G, Vallerie V, et al. Medical therapy for pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:35S-62.
-
(2004)
Chest
, vol.126
-
-
Badesch, D.B.1
Abman, S.H.2
Ahearn, G.S.3
Barst, R.J.4
Simonneau, G.5
Vallerie, V.6
-
2
-
-
34250870730
-
Medical therapy for pulmonary arterial hypertension: Updated ACCP evidence-based clinical practice guidelines
-
DOI 10.1378/chest.06-2674
-
Badesch DB, Abman SH, Simonneau G, Rubin LJ, Mclaughlin VV. Medical therapy for pulmonary arterial hypertension. Updated ACCP evidence-based clinical practice guidelines. Chest 2007;131:1917-28. (Pubitemid 46981654)
-
(2007)
Chest
, vol.131
, Issue.6
, pp. 1917-1928
-
-
Badesch, D.B.1
Abman, S.H.2
Simonneau, G.3
Rubin, L.J.4
McLaughlin, V.V.5
-
3
-
-
2942592213
-
Cardiovascular disease in non-western countries
-
DOI 10.1056/NEJMp048024
-
Reddy KS. Cardiovascular disease in non-western countries. N Engl J Med 2004;350:2438-40. (Pubitemid 38736540)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.24
, pp. 2438-2440
-
-
Reddy, K.S.1
-
4
-
-
47849100456
-
Pediatric heart care in india
-
Kumar RK, Shrivastava S. Pediatric heart care in India. Heart 2008;94:984-90.
-
(2008)
Heart
, vol.94
, pp. 984-990
-
-
Kumar, R.K.1
Shrivastava, S.2
-
7
-
-
0242294315
-
Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease
-
Narula J, Virmani R, Reddy KS, Tandon R, editors Washington, DC; American Registry of Pathology;
-
Kumar RK, Rammohan R, Narula J, Kaplan EL. Epidemiology of streptococcal pharyngitis, rheumatic fever and rheumatic heart disease. In: Narula J, Virmani R, Reddy KS, Tandon R, editors. Rheumatic fever, Washington, DC; American Registry of Pathology; 1999. p. 41-78.
-
(1999)
Rheumatic Fever
, pp. 41-78
-
-
Kumar, R.K.1
Rammohan, R.2
Narula, J.3
Kaplan, E.L.4
-
8
-
-
3142692425
-
Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines
-
McGoon M, Gutterman D, Steen V, Barst R, McCrory DC, Fortin TA, et al. Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004;126:14S-34.
-
(2004)
Chest
, vol.126
-
-
McGoon, M.1
Gutterman, D.2
Steen, V.3
Barst, R.4
McCrory, D.C.5
Fortin, T.A.6
-
9
-
-
0029033224
-
Increased plasma serotonin in primary pulmonary hypertension
-
Herve P, Launay JM, Scrobohaci ML, Brenot F, Simonneau G, Petitpretz P, et al. Increased plasma serotonin in primary pulmonary hypertension. Am J Med 1995;99:249-54.
-
(1995)
Am J Med
, vol.99
, pp. 249-254
-
-
Herve, P.1
Launay, J.M.2
Scrobohaci, M.L.3
Brenot, F.4
Simonneau, G.5
Petitpretz, P.6
-
10
-
-
0026628265
-
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
-
Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
-
(1992)
N Engl J Med
, vol.327
, pp. 70-75
-
-
Christman, B.W.1
McPherson, C.D.2
Newman, J.H.3
King, G.A.4
Bernard, G.R.5
Groves, B.M.6
-
11
-
-
34548404246
-
Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension
-
White RJ, Meoli DF, Swarthout RF, Kallop DY, Galaria II, Harvey JL, et al. Plexiform-like lesions and increased tissue factor expression in a rat model of severe pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007;293:583-90.
-
(2007)
Am J Physiol Lung Cell Mol Physiol
, vol.293
, pp. 583-590
-
-
White, R.J.1
Meoli, D.F.2
Swarthout, R.F.3
Kallop, D.Y.4
Galaria, I.I.5
Harvey, J.L.6
-
12
-
-
21744460365
-
Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells
-
DOI 10.1096/fj.04-3261fje
-
Sakao S, Taraseviciene-Stewart L, Lee JD, Wood K, Cool CD, Voelkel NF. Initial apoptosis is followed by increased proliferation of apoptosis-resistant endothelial cells. Faseb J 2005;19:1178-80. (Pubitemid 40946457)
-
(2005)
FASEB Journal
, vol.19
, Issue.9
, pp. 1178-1180
-
-
Sakao, S.1
Taraseviciene-Stewart, L.2
Lee, J.D.3
Wood, K.4
Cool, C.D.5
Voelkel, N.F.6
-
13
-
-
2342483718
-
Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation
-
Landsberg JW, Yuan JX. Calcium and TRP channels in pulmonary vascular smooth muscle cell proliferation. News Physiol Sci 2004;19:44-50.
-
(2004)
News Physiol Sci
, vol.19
, pp. 44-50
-
-
Landsberg, J.W.1
Yuan, J.X.2
-
14
-
-
0035859940
-
1 and bone morphogenetic proteins
-
Morrell NW, Yang X, Upton PD, Jourdan KB, Morgan N, Sheares KK, et al. Altered growth responses of pulmonary artery smooth muscle cells from patients with primary pulmonary hypertension to transforming growth factor-beta(1) and bone morphogenetic proteins. Circulation 2001;104:790-5. (Pubitemid 32762677)
-
(2001)
Circulation
, vol.104
, Issue.7
, pp. 790-795
-
-
Morrell, N.W.1
Yang, X.2
Upton, P.D.3
Jourdan, K.B.4
Morgan, N.5
Sheares, K.K.6
Trembath, R.C.7
-
15
-
-
34247198299
-
Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension
-
DOI 10.1152/ajplung.00309.2006
-
McMurtry MS, Moudgil R, Hashimoto K, Bonnet S, Michelakis ED, Archer SL. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol 2007;292:L872-8. (Pubitemid 46608233)
-
(2007)
American Journal of Physiology - Lung Cellular and Molecular Physiology
, vol.292
, Issue.4
-
-
McMurtry, M.S.1
Moudgil, R.2
Hashimoto, K.3
Bonnet, S.4
Michelakis, E.D.5
Archer, S.L.6
-
16
-
-
20444483234
-
Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension
-
DOI 10.1172/JCI23203
-
McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, et al. Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest 2005;115:1479-91. (Pubitemid 40814657)
-
(2005)
Journal of Clinical Investigation
, vol.115
, Issue.6
, pp. 1479-1491
-
-
McMurtry, M.S.1
Archer, S.L.2
Altieri, D.C.3
Bonnet, S.4
Haromy, A.5
Harry, G.6
Bonnet, S.7
Puttagunta, L.8
Michelakis, E.D.9
-
17
-
-
0036014810
-
Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension?
-
DOI 10.1067/mlc.2002.122181
-
Eddahibi S, Raffestin B, Hamon M, Adnot S. Is the serotonin transporter involved in the pathogenesis of pulmonary hypertension? J Lab Clin Med 2002;139:194-201. (Pubitemid 34557354)
-
(2002)
Journal of Laboratory and Clinical Medicine
, vol.139
, Issue.4
, pp. 194-201
-
-
Eddahibi, S.1
Raffestin, B.2
Hamon, M.3
Adnot, S.4
-
18
-
-
0037204990
-
Signal transduction by the tgf-beta superfamily
-
Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science 2002;296:1646-7.
-
(2002)
Science
, vol.296
, pp. 1646-1647
-
-
Attisano, L.1
Wrana, J.L.2
-
19
-
-
40749109217
-
Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension
-
DOI 10.1152/physiolgenomics.00169.2007
-
Moreno-Vinasco L, Gomberg-Maitland M, Maitland ML, Desai AA, Singleton PA, Sammani S, et al. Genomic assessment of a multikinase inhibitor, sorafenib, in a rodent model of pulmonary hypertension. Physiol Genomics 2008;33:278-91. (Pubitemid 351629535)
-
(2008)
Physiological Genomics
, vol.33
, Issue.2
, pp. 278-291
-
-
Moreno-Vinasco, L.1
Gomberg-Maitland, M.2
Maitland, M.L.3
Desai, A.A.4
Singleton, P.A.5
Sammani, S.6
Sam, L.7
Liu, Y.8
Husain, A.N.9
Lang, R.M.10
Ratain, M.J.11
Lussier, Y.A.12
Garcia, J.G.N.13
-
20
-
-
0033838125
-
Familial primary pulmonary hypertension (Gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene
-
DOI 10.1086/303059
-
Deng Z, Morse JH, Slager SL, Cuervo N, Moore KJ, Venetos G, et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene. Am J Hum Genet 2000;67:737-44. (Pubitemid 30659603)
-
(2000)
American Journal of Human Genetics
, vol.67
, Issue.3
, pp. 737-744
-
-
Deng, Z.1
Morse, J.H.2
Slager, S.L.3
Cuervo, N.4
Moore, K.J.5
Venetos, G.6
Kalachikov, S.7
Cayanis, E.8
Fischer, S.G.9
Barst, R.J.10
Hodge, S.E.11
Knowles, J.A.12
-
21
-
-
0033623296
-
Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding bmpr-ii, a receptor member of the tgf-beta family
-
Thomson JR, Machado RD, Pauciulo MW, Morgan NV, Humbert M, Elliott GC, et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 2000;37:741-5.
-
(2000)
J Med Genet
, vol.37
, pp. 741-745
-
-
Thomson, J.R.1
MacHado, R.D.2
Pauciulo, M.W.3
Morgan, N.V.4
Humbert, M.5
Elliott, G.C.6
-
22
-
-
54049138069
-
Emerging concepts and translational priorities in pulmonary arterial hypertension
-
Michelakis ED, Wilkins MR, Rabinovitch M. Emerging concepts and translational priorities in pulmonary arterial hypertension. Circulation 2008;118:1486-95.
-
(2008)
Circulation
, vol.118
, pp. 1486-1495
-
-
Michelakis, E.D.1
Wilkins, M.R.2
Rabinovitch, M.3
-
23
-
-
0037623284
-
Primary pulmonary hypertension
-
DOI 10.1016/S0140-6736(03)13167-4
-
Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-44. (Pubitemid 36566349)
-
(2003)
Lancet
, vol.361
, Issue.9368
, pp. 1533-1544
-
-
Runo, J.R.1
Loyd, J.E.2
-
24
-
-
1642453778
-
Endothelial dysfunction in pulmonary hypertension
-
Budhiraja R, Tuder RM, Hassoun PM. Endothelial dysfunction in pulmonary hypertension. Circulation 2004;109:159-61.
-
(2004)
Circulation
, vol.109
, pp. 159-161
-
-
Budhiraja, R.1
Tuder, R.M.2
Hassoun, P.M.3
-
25
-
-
9444287592
-
Appetite-suppressant drugs and the risk of primary pulmonary hypertension
-
DOI 10.1056/NEJM199608293350901
-
Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, et al. Appetite suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med 1996;335:609-16. (Pubitemid 26277950)
-
(1996)
New England Journal of Medicine
, vol.335
, Issue.9
, pp. 609-616
-
-
Abenhaim, L.1
Moride, Y.2
Brenot, F.3
Rich, S.4
Benichou, J.5
Kurz, X.6
Higenbottam, T.7
Oakley, C.8
Wouters, E.9
Aubier, M.10
Simonneau, G.11
Begaud, B.12
-
26
-
-
2942522878
-
Clinical classification of pulmonary hypertension
-
DOI 10.1016/j.jacc.2004.02.037, PII S0735109704004759
-
Simmoneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Dominoghetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;43:5S-12S. (Pubitemid 38759712)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.12 SUPPL.
-
-
Simonneau, G.1
Galie, N.2
Rubin, L.J.3
Langleben, D.4
Seeger, W.5
Domenighetti, G.6
Gibbs, S.7
Lebrec, D.8
Speich, R.9
Beghetti, M.10
Rich, S.11
Fishman, A.12
-
27
-
-
2942603006
-
Diagnosis and differential assessment of pulmonary arterial hypertension
-
DOI 10.1016/j.jacc.2004.02.032, PII S0735109704004413
-
Barst RJ, McGoon M, Torbicki A, Sitbon O, Krowka MJ, Olschewski H, et al. Diagnosis and differential assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:40S-7S. (Pubitemid 38759716)
-
(2004)
Journal of the American College of Cardiology
, vol.43
, Issue.12 SUPPL.
-
-
Barst, R.J.1
McGoon, M.2
Torbicki, A.3
Sitbon, O.4
Krowka, M.J.5
Olschewski, H.6
Gaine, S.7
-
28
-
-
67649579669
-
Updated clinical classification of pulmonary hypertension
-
Simonneau G, Robbins IM, Beghetti M, Channick RN, Delcroix M, Denton CP, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2009;54:S43-54.
-
(2009)
J Am Coll Cardiol
, vol.54
-
-
Simonneau, G.1
Robbins, I.M.2
Beghetti, M.3
Channick, R.N.4
Delcroix, M.5
Denton, C.P.6
-
29
-
-
33749076068
-
Electrocardiography in the diagnosis of right ventricular hypertrophy in children
-
DOI 10.1542/peds.2005-2985
-
Puchalski MD, Lozier JS, Bradley DJ, Minich LL, Tani LY. Electrocardiography in the diagnosis of right ventricular hypertrophy in children. Pediatrics 2006;118:1052-5. (Pubitemid 46090045)
-
(2006)
Pediatrics
, vol.118
, Issue.3
, pp. 1052-1055
-
-
Puchalski, M.D.1
Lozier, J.S.2
Bradley, D.J.3
Minich, L.L.4
Tani, L.Y.5
-
30
-
-
0037012377
-
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
-
DOI 10.1016/S0735-1097(02)01744-8, PII S0735109702017448
-
Raymond R, Hinderliter A, Willis P, Ralph D, Caldwell EJ, Williams W, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39:1214-9. (Pubitemid 34267428)
-
(2002)
Journal of the American College of Cardiology
, vol.39
, Issue.7
, pp. 1214-1219
-
-
Raymond, R.J.1
Hinderliter, A.L.2
Willis IV, P.W.3
Ralph, D.4
Caldwell, E.J.5
Williams, W.6
Ettinger, N.A.7
Hill, N.S.8
Summer, W.R.9
De Boisblanc, B.10
Schwartz, T.11
Koch, G.12
Clayton, L.M.13
Jobsis, M.M.14
Crow, J.W.15
Long, W.16
-
31
-
-
33646476400
-
Serum n-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension
-
Fijalkowska A, Kurzyna M, Torbicki A, Szewczysk G, Florczyk M, Pruszczyk P, et al. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest 2006;129:1313-21.
-
(2006)
Chest
, vol.129
, pp. 1313-1321
-
-
Fijalkowska, A.1
Kurzyna, M.2
Torbicki, A.3
Szewczysk, G.4
Florczyk, M.5
Pruszczyk, P.6
-
32
-
-
0032814812
-
Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension
-
Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999;160:487-92. (Pubitemid 29380662)
-
(1999)
American Journal of Respiratory and Critical Care Medicine
, vol.160
, Issue.2
, pp. 487-492
-
-
Nagaya, N.1
Uematsu, M.2
Satoh, T.3
Kyotani, S.4
Sakamaki, F.5
Nakanishi, N.6
Yamagishi, M.7
Kunieda, T.8
Miyatake, K.9
-
33
-
-
0042433550
-
Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension
-
DOI 10.1161/01.CIR.0000084544.54513.E2
-
Torbicki A, Kurzyna M, Kuca P, Fijalkowska A, Sikora J, Florczyk M, et al. Detectable serum cardiac troponin T as a marker of poor prognosis among patients with chronic precapillary pulmonary hypertension. Circulation 2003;108:844-8. (Pubitemid 37022127)
-
(2003)
Circulation
, vol.108
, Issue.7
, pp. 844-848
-
-
Torbicki, A.1
Kurzyna, M.2
Kuca, P.3
Fijalkowska, A.4
Sikora, J.5
Florczyk, M.6
Pruszczyk, P.7
Burakowski, J.8
Wawrzynska, L.9
-
34
-
-
34547651204
-
Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension
-
DOI 10.1016/j.amjcard.2007.03.094, PII S0002914907009691
-
Sanz J, Dellegrottaglie S, Kariisa M, Sulica R, Poon M, O'Donnell TP, et al. Prevalence and correlates of septal delayed contrast enhancement in patients with pulmonary hypertension. Am J Cardiol 2007;15:731-5. (Pubitemid 47223155)
-
(2007)
American Journal of Cardiology
, vol.100
, Issue.4
, pp. 731-735
-
-
Sanz, J.1
Dellegrottaglie, S.2
Kariisa, M.3
Sulica, R.4
Poon, M.5
O'Donnell, T.P.6
Mehta, D.7
Fuster, V.8
Rajagopalan, S.9
-
35
-
-
0037332125
-
The 6-Minute walk test: A quick measure of functional status in elderly adults
-
Enright PL, McBurnie MA, Bittner V, Tracy RP, McNamara R, Arnold A, et al. The 6-minute walk test: A quick measure of functional status in elderly adults. Chest 2003;123:387.
-
(2003)
Chest
, vol.123
, pp. 387
-
-
Enright, P.L.1
McBurnie, M.A.2
Bittner, V.3
Tracy, R.P.4
McNamara, R.5
Arnold, A.6
-
36
-
-
84856372420
-
New predictors of outcome in idiopathic pulmonary arterial hypertension
-
Kawut SM, Horn EM, Berekashvili KK, Garofano RP, Goldsmithth RL, Wildsmit AC, et al. New predictors of outcome in idiopathic pulmonary arterial hypertension. Chest 2008;134:139-45.
-
(2008)
Chest
, vol.134
, pp. 139-145
-
-
Kawut, S.M.1
Horn, E.M.2
Berekashvili, K.K.3
Garofano, R.P.4
Goldsmithth, R.L.5
Wildsmit, A.C.6
-
37
-
-
0026632785
-
The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension
-
Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med 1992;327:76-81.
-
(1992)
N Engl J Med
, vol.327
, pp. 76-81
-
-
Rich, S.1
Kaufmann, E.2
Levy, P.S.3
-
38
-
-
0026628265
-
An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension
-
Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, et al. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med 1992;327:70-5.
-
(1992)
N Engl J Med
, vol.327
, pp. 70-75
-
-
Christman, B.W.1
McPherson, C.D.2
Newman, J.H.3
King, G.A.4
Bernard, G.R.5
Groves, B.M.6
-
39
-
-
2942549282
-
Prostanoid therapy for pulmonary arterial hypertension
-
Badesch DB, McLaughlin VV, Delcroix M, Vizza CD, Olschewski H, Sitbon O, et al. Prostanoid therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2004;43:56S-61.
-
(2004)
J Am Coll Cardiol
, vol.43
-
-
Badesch, D.B.1
McLaughlin, V.V.2
Delcroix, M.3
Vizza, C.D.4
Olschewski, H.5
Sitbon, O.6
-
40
-
-
0038037766
-
Beraprost therapy for pulmonary arterial hypertension
-
DOI 10.1016/S0735-1097(03)00463-7
-
Barst RJ, McGoon M, McLAughlin V, Tapson V, Oudiz R, Shapiro S, et al. Beraprost therapy for pulmonary arterial hypertension. J Am Coll Cardiol 2003;41:2119-25. (Pubitemid 36724255)
-
(2003)
Journal of the American College of Cardiology
, vol.41
, Issue.12
, pp. 2119-2125
-
-
Barst, R.J.1
McGoon, M.2
McLaughlin, V.3
Tapson, V.4
Oudiz, R.5
Shapiro, S.6
Robbins, I.M.7
Channick, R.8
Badesch, D.9
Rayburn, B.K.10
Flinchbaugh, R.11
Sigman, J.12
Arneson, C.13
Jeffs, R.14
-
41
-
-
0030031888
-
A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
-
Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-302.
-
(1996)
N Engl J Med
, vol.334
, pp. 296-302
-
-
Barst, R.J.1
Rubin, L.J.2
Long, W.A.3
McGoon, M.D.4
Rich, S.5
Badesch, D.B.6
-
42
-
-
0037086133
-
Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial
-
Simonneau G, Barst RJ, Galie N, Naeije R, Rich S, Bourge RC, et al. Continuous subcutaneous infusion of treprostinil, a prostacyclin analog, in patients with pulmonary arterial hypertension: A double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2002;165:800-4. (Pubitemid 34229650)
-
(2002)
American Journal of Respiratory and Critical Care Medicine
, vol.165
, Issue.6
, pp. 800-804
-
-
Simonneau, G.1
Barst, R.J.2
Galie, N.3
Naeije, R.4
Rich, S.5
Bourge, R.C.6
Keogh, A.7
Oudiz, R.8
Frost, A.9
Blackburn, S.D.10
Crow, J.W.11
Rubin, L.J.12
-
43
-
-
33645119109
-
Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicentre, open label, 12-week trial
-
Tapson VF, Gomberg-Maitland M, McLaughlin VV, Benza RL, Widlitz AC, Krichman A, et al. Safety and efficacy of IV treprostinil for pulmonary arterial hypertension: A prospective, multicentre, open label, 12-week trial. Chest 2006;129:683-8.
-
(2006)
Chest
, vol.129
, pp. 683-688
-
-
Tapson, V.F.1
Gomberg-Maitland, M.2
McLaughlin, V.V.3
Benza, R.L.4
Widlitz, A.C.5
Krichman, A.6
-
44
-
-
0036682273
-
Inhaled iloprost for severe pulmonary hypertension
-
DOI 10.1056/NEJMoa020204
-
Olschewski H, Simonneau G, Galie N, Higenbottam T, Naije R, Rubin LJ, et al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002;347:322-9. (Pubitemid 34815354)
-
(2002)
New England Journal of Medicine
, vol.347
, Issue.5
, pp. 322-329
-
-
Olschewski, H.1
Simonneau, G.2
Galie, N.3
Higenbottam, T.4
Naeije, R.5
Rubin, L.J.6
Nikkho, S.7
Speich, R.8
Hoeper, M.M.9
Behr, J.10
Winkler, J.11
Sitbon, O.12
Popov, W.13
Ardeschir Ghofrani, H.14
Manes, A.15
Kiely, D.G.16
Ewert, R.17
Meyer, A.18
Corris, P.A.19
Delcroix, M.20
Gomez-Sanchez, M.21
Siedentop, H.22
Seeger, W.23
more..
-
45
-
-
21544449424
-
Clinical efficacy and survival with first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
-
DOI 10.1093/eurheartj/ehi283
-
Opitz CF, Wensel R, Winkler J, Halank M, Bruch L, Kleber FX, et al. Clinical efficacy and survival with first line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension. Eur Heart J 2005;26:1895-902. (Pubitemid 41253303)
-
(2005)
European Heart Journal
, vol.26
, Issue.18
, pp. 1895-1902
-
-
Opitz, C.F.1
Wensel, R.2
Winkler, J.3
Halank, M.4
Bruch, L.5
Kleber, F.-X.6
Hoffken, G.7
Anker, S.D.8
Negassa, A.9
Felix, S.B.10
Hetzer, R.11
Ewert, R.12
-
47
-
-
13844280943
-
Survival with first-line bosentan in patients with primary pulmonary hypertension
-
DOI 10.1183/09031936.05.00054804
-
Mclaughlin VV, Sitbon O, Badesch DB, Barst RJ, Black C, Galie N, et al. Survival with first line Bosentan in patients with primary pulmonary hypertension. Eur Respir J 2005;25:244-9. (Pubitemid 40246523)
-
(2005)
European Respiratory Journal
, vol.25
, Issue.2
, pp. 244-249
-
-
McLaughlin, V.V.1
Sitbon, O.2
Badesch, D.B.3
Barst, R.J.4
Black, C.5
Galie, N.6
Rainisio, M.7
Simonneau, G.8
Rubin, L.J.9
-
48
-
-
27744444638
-
Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol
-
DOI 10.1136/thx.2005.040618
-
Sitbon O, McLaughlin VV, Badesch DB, Barst RJ, Black C, Galiè N, et al. Survival in patients with class III idiopathic pulmonary arterial hypertension treated with first line oral bosentan compared with an historical cohort of patients started on intravenous epoprostenol. Thorax 2005;60:1025-30. (Pubitemid 41705471)
-
(2005)
Thorax
, vol.60
, Issue.12
, pp. 1025-1030
-
-
Sitbon, O.1
McLaughlin, V.V.2
Badesch, D.B.3
Barst, R.J.4
Black, C.5
Galie, N.6
Humbert, M.7
Rainisio, M.8
Rubin, L.J.9
Simonneau, G.10
-
49
-
-
0344406959
-
Pharmacokinetics, safety, and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension
-
DOI 10.1016/S0009-9236(03)00005-5
-
Barst RJ, Ivy D, Dingemanse J, Widlitz A, Schmitt K, Doran A, et al. Pharmokinetics, safety and efficacy of bosentan in pediatric patients with pulmonary arterial hypertension. Clin Pharmocol Ther 2003;73:372-82. (Pubitemid 36403597)
-
(2003)
Clinical Pharmacology and Therapeutics
, vol.73
, Issue.4
, pp. 372-382
-
-
Barst, R.J.1
Ivy, D.2
Dingemanse, J.3
Widlitz, A.4
Schmitt, K.5
Doran, A.6
Bingaman, D.7
Nguyen, N.8
Gaitonde, M.9
Van Giersbergen, P.L.M.10
-
50
-
-
44949256178
-
Endothelin receptor antagonists for pulmonary arterial hypertension: Rationale and place in therapy
-
DOI 10.2165/00129784-200808030-00004
-
Price LC, Howard LS. Endothelin receptor antagonists for pulmonary arterial hypertension. Rationale and place in therapy. Am J Cardiovasc Drugs 2008;8:171-85. (Pubitemid 351812270)
-
(2008)
American Journal of Cardiovascular Drugs
, vol.8
, Issue.3
, pp. 171-185
-
-
Price, L.C.1
Howard, L.S.G.E.2
-
51
-
-
79960992464
-
Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension
-
Safdar Z. Effect of transition from sitaxsentan to ambrisentan in pulmonary arterial hypertension. Vasc Health Risk Manag 2011;7:119-24.
-
(2011)
Vasc Health Risk Manag
, vol.7
, pp. 119-124
-
-
Safdar, Z.1
-
52
-
-
26444534291
-
Sildenafil citrate therapy for pulmonary arterial hypertension
-
DOI 10.1056/NEJMoa050010
-
Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, et al. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med 2005;353:2148-57. (Pubitemid 41653106)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.20
, pp. 2148-2157
-
-
Galie, N.1
Ghofrani, H.A.2
Torbicki, A.3
Barst, R.J.4
Rubin, L.J.5
Badesch, D.6
Fleming, T.7
Parpia, T.8
Burgess, G.9
Branzi, A.10
Grimminger, F.11
Kurzyna, M.12
Simonneau, G.13
-
53
-
-
4644232338
-
Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study
-
DOI 10.1016/j.jacc.2004.06.060, PII S0735109704013622
-
Ghofrani AH, Voswinckel R, Reichenberger F, Olschewski H, Haredza P, Karadas B, et al. Differences in Hemodynamic and Oxygenation Responses to Three Different Phosphodiesterase-5 Inhibitors in Patients With Pulmonary Arterial Hypertension. J Am Coll Cardiol 2004;44:1488-96. (Pubitemid 39303954)
-
(2004)
Journal of the American College of Cardiology
, vol.44
, Issue.7
, pp. 1488-1496
-
-
Ghofrani, H.A.1
Voswinckel, R.2
Reichenberger, F.3
Olschewski, H.4
Haredza, P.5
Karadas, B.6
Schermuly, R.T.7
Weissmann, N.8
Seeger, W.9
Grimminger, F.10
-
54
-
-
47549106387
-
Treprostinil-based therapy in the treatment of moderate-to-severe pulmonary arterial hypertension
-
DOI 10.1378/chest.07-2111
-
Benza RI, Rayburn BK, Tallaj JA, Pamboukian SV, Bourge RC. Treprostinil based therapy in the treatment of moderate to severe pulmonary arterial hypertension. Chest 2008;134:139-45. (Pubitemid 352008775)
-
(2008)
Chest
, vol.134
, Issue.1
, pp. 139-145
-
-
Benza, R.L.1
Rayburn, B.K.2
Tallaj, J.A.3
Pamboukian, S.V.4
Bourge, R.C.5
-
55
-
-
0036490437
-
Graded balloon atrial septostomy in sever pulmonary hypertension
-
Kothari SS, Yusuf A, Juneja R, Yadav R, Naik N. Graded balloon atrial septostomy in sever pulmonary hypertension. Indian Heart J 2002;54:164-9.
-
(2002)
Indian Heart J
, vol.54
, pp. 164-169
-
-
Kothari, S.S.1
Yusuf, A.2
Juneja, R.3
Yadav, R.4
Naik, N.5
-
56
-
-
0012293938
-
The registry of the international society for heart and lung transplantation: 19 th official report-2002
-
Hertz M, Taylor D, Trulock E, Boucek MM, Mohacsi PJ, Edwards LB, et al. The Registry of the International Society for Heart and Lung Transplantation: 19 th official report-2002. J Heart Lung Transplant 2002;21:950.
-
(2002)
J Heart Lung Transplant
, vol.21
, pp. 950
-
-
Hertz, M.1
Taylor, D.2
Trulock, E.3
Boucek, M.M.4
Mohacsi, P.J.5
Edwards, L.B.6
-
58
-
-
4544361900
-
Biventricular support with the Jarvik 2000 ventricular assist device in a calf model of pulmonary hypertension
-
DOI 10.1097/01.MAT.0000139304.34821.F1
-
Kindo M, Radovancevic B, Gregoric ID, Conger JL, Kadipasaoglu K, Tamez DA, et al. Biventricular support with a Jarvik 200-ventricular assist device in a calf model of pulmonary hypertension. ASAIO J 2004;50:444-50. (Pubitemid 39237953)
-
(2004)
ASAIO Journal
, vol.50
, Issue.5
, pp. 444-450
-
-
Kindo, M.1
Radovancevic, B.2
Gregoric, I.D.3
Conger, J.L.4
Kadipasaoglu, K.5
Tamez, D.A.6
Moore, S.R.7
Golden, K.A.8
Robert, K.9
Frazier, O.H.10
-
59
-
-
0031753080
-
Angiotensin-converting enzyme inhibition delays pulmonary vascular neointimal formation
-
Okada K, Bernstein ML, Zhang W, Schuster DP, Botney MD. Angiotensin converting enzyme inhibition delays pulmonary vascular neointimal formation. Am J Respir Crit Care Med 1998;158:939-50. (Pubitemid 28449464)
-
(1998)
American Journal of Respiratory and Critical Care Medicine
, vol.158
, Issue.3
, pp. 939-950
-
-
Okada, K.1
Bernstein, M.L.2
Zhang, W.3
Schuster, D.P.4
Botney, M.D.5
-
61
-
-
0037151645
-
Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: Prognostic factors and survival
-
DOI 10.1016/S0735-1097(02)02012-0, PII S0735109702020120
-
Sitbon O, Humbert M, Nunes H, Parent F, Garcia G, Herve P, et al. Long term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. J Am Coll Cardiol 2002;40:780-8. (Pubitemid 34925627)
-
(2002)
Journal of the American College of Cardiology
, vol.40
, Issue.4
, pp. 780-788
-
-
Sitbon, O.1
Humbert, M.2
Nunes, H.3
Parent, F.4
Garcia, G.5
Herve, P.6
Rainisio, M.7
Simonneau, G.8
-
62
-
-
0034702908
-
Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension
-
Nagaya N, Nishikimi T, Uematsu M, Satoh T, Kyotani S, Sakamaki F, et al. Plasma brain natriuretic peptide as a prognostic indicator in patients with primary pulmonary hypertension. Circulation 2000;102:865-70.
-
(2000)
Circulation
, vol.102
, pp. 865-870
-
-
Nagaya, N.1
Nishikimi, T.2
Uematsu, M.3
Satoh, T.4
Kyotani, S.5
Sakamaki, F.6
-
63
-
-
0037012377
-
Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension
-
DOI 10.1016/S0735-1097(02)01744-8, PII S0735109702017448
-
Raymond RJ, Hinderliter AL, Willis PW, Ralph D, Caldwell EJ, Williams W, et al. Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension. J Am Coll Cardiol 2002;39:1214-9. (Pubitemid 34267428)
-
(2002)
Journal of the American College of Cardiology
, vol.39
, Issue.7
, pp. 1214-1219
-
-
Raymond, R.J.1
Hinderliter, A.L.2
Willis IV, P.W.3
Ralph, D.4
Caldwell, E.J.5
Williams, W.6
Ettinger, N.A.7
Hill, N.S.8
Summer, W.R.9
De Boisblanc, B.10
Schwartz, T.11
Koch, G.12
Clayton, L.M.13
Jobsis, M.M.14
Crow, J.W.15
Long, W.16
-
64
-
-
0038369941
-
Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension
-
DOI 10.1172/JCI200317500
-
Petkov V, Mosgoeller W, Ziesche R, Raderer M, Stiebellehner L, Vonbank K, et al. Vasoactive intestinal peptide as a new drug for treatment of primary pulmonary hypertension. J Clin Invest 2003;111:1339-46. (Pubitemid 36554704)
-
(2003)
Journal of Clinical Investigation
, vol.111
, Issue.9
, pp. 1339-1346
-
-
Petkov, V.1
Mosgoeller, W.2
Ziesche, R.3
Raderer, M.4
Stiebellehner, L.5
Vonbank, K.6
Funk, G.-C.7
Hamilton, G.8
Novotny, C.9
Burian, B.10
Block, L.-H.11
-
65
-
-
78651369037
-
Gene therapy for pulmonary hypertension: Prospects and challenges
-
Reynolds PN. Gene therapy for pulmonary hypertension: prospects and challenges. Expert Opin. Biol Ther 2011;11:133-43.
-
(2011)
Expert Opin. Biol Ther
, vol.11
, pp. 133-143
-
-
Reynolds, P.N.1
-
66
-
-
25444484658
-
Imatinib for the treatment of pulmonary arterial hypertension [1]
-
DOI 10.1056/NEJMc051946
-
Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 2005;353:1412-3. (Pubitemid 41362714)
-
(2005)
New England Journal of Medicine
, vol.353
, Issue.13
, pp. 1412-1413
-
-
Ghofrani, H.A.1
Seeger, W.2
Grimminger, F.3
-
67
-
-
33746745449
-
Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension [3]
-
Patterson KC, Weissmann A, Ahmadi T, Farber HW. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 2006;145:152-3. (Pubitemid 46780594)
-
(2006)
Annals of Internal Medicine
, vol.145
, Issue.2
, pp. 152-153
-
-
Patterson, K.C.1
Weissmann, A.2
Ahmadi, T.3
Farber, H.W.4
-
68
-
-
67449105737
-
Rho A and rho kinase activation in human pulmonary hypertension: Role of 5-Ht signalling
-
Guilluy C, Eddahibi S, Agard C, Guignabert C, Izikki M, Tu L, et al. Rho A and Rho kinase activation in human pulmonary hypertension: Role of 5-HT signalling. Am J Respir Crit Care Med 2009;179:1151-8.
-
(2009)
Am J Respir Crit Care Med
, vol.179
, pp. 1151-1158
-
-
Guilluy, C.1
Eddahibi, S.2
Agard, C.3
Guignabert, C.4
Izikki, M.5
Tu, L.6
|